Latest news with #SBIR
Fibre2Fashion
12-06-2025
- Business
- Fibre2Fashion
CCI, Aurora collaborate on High-Performance aerospace structures
Continuous Composites (CCI), a leader in advanced composite manufacturing, has been awarded a U.S. Army Small Business Innovation Research (SBIR) project in collaboration with Aurora Flight Sciences, a Boeing Company, to develop next-generation fuselage structures for launched effects. The project, which originated as a Navy-funded initiative, was successfully transitioned to the Army following the completion of Phase One and is now entering Phase Two with a $2 million contract. The initiative focuses on enhancing the structural integrity of systems designed to be launched from canisters—similar to missile deployment systems—and aims to set new performance benchmarks for these air-launched platforms. Aurora is providing critical flight load data and geometric designs, which Continuous Composites will use to develop optimized fuselage structures through its patented CF3D technology. Continuous Composites (CCI), in collaboration with Aurora Flight Sciences, has secured a $2 million US Army SBIR Phase Two contract to develop next-gen fuselage structures for launched effects using its CF3D technology. The project aims to create lightweight, high-strength designs that enhance payload capacity and efficiency in aerospace defence systems. Leveraging its expertise in fiber steering and topology optimization, CCI will engineer lightweight, high-performance fuselage designs that maximize internal volume, directly increasing payload capacity without compromising overall performance. This innovative approach reimagines internal architecture, using less material while embedding greater strength into the design, reducing weight and improving efficiency for mission-critical aerospace applications. "This collaboration represents a powerful convergence of aerospace innovation and cutting-edge manufacturing technology," said Steve Starner, CEO of Continuous Composites . "By pairing Aurora's flight systems expertise with our CF3D technology, we are pushing the limits of what's possible in the development of launched effect structures, delivering more agile, functional, and cost-effective solutions for defense applications." The SBIR contract marks a pivotal step in scaling CF3D for high-performance defense applications, positioning Continuous Composites as a strategic supplier of lightweight, rapidly deployable aerospace solutions to the Department of Defense. This funding validates the potential of CF3D to revolutionize structural components for launched effects and other aerospace technologies. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (RM)
Yahoo
11-06-2025
- Business
- Yahoo
Solideon Announces $1.25 Million AFWERX Contract
BERKELEY, Calif., June 11, 2025--(BUSINESS WIRE)--(Additive Space Technologies Inc., d.b.a. Solideon) announces it has been selected by AFWERX for a Direct-to-Phase II contract in the amount of $1.25 million focused on developing a single pallet additive manufacturing cell that is capable of flexibly manufacturing critical systems across expeditionary environments. to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018, which expanded the range of innovations the DAF funded, and now, on May 21st, 2025, Additive Space Technologies Inc, d.b.a Solideon will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. Quote From Company "The future of industrial power isn't centralized — it's deployable. This award is a signal that the Department of the Air Force is ready to break from the past and lead with agility. With this contract, we're building the foundation for a world where manufacturing happens not in factories but wherever the mission demands — from airbases to shipyards and, eventually, orbit." CEO Oluseun Taiwo The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. About Additive Space Technologies Inc., d.b.a. Solideon Solideon is revolutionizing manufacturing by transforming readily available robotic arms into multi-robotic-enabled factories. This innovative approach empowers end-users with the capability to robotically weld, fabricate, and assemble entire structures on-site. By doing so, Solideon is fundamentally reshaping how the industrial base approaches the manufacturing of critical assets, such as ships, submarines, and other large vehicles. About AFRL The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space, and cyberspace forces. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit About AFWERX As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at four hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has awarded over 10,400 contracts worth more than $7.24 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: View source version on Contacts Company Press Contact: Kait EwoldtCreative Director and Strategic Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
Business Wire
11-06-2025
- Business
- Business Wire
Solideon Announces $1.25 Million AFWERX Contract
BERKELEY, Calif.--(BUSINESS WIRE)--(Additive Space Technologies Inc., d.b.a. Solideon) announces it has been selected by AFWERX for a Direct-to-Phase II contract in the amount of $1.25 million focused on developing a single pallet additive manufacturing cell that is capable of flexibly manufacturing critical systems across expeditionary environments. to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018, which expanded the range of innovations the DAF funded, and now, on May 21st, 2025, Additive Space Technologies Inc, d.b.a Solideon will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. Quote From Company 'The future of industrial power isn't centralized — it's deployable. This award is a signal that the Department of the Air Force is ready to break from the past and lead with agility. With this contract, we're building the foundation for a world where manufacturing happens not in factories but wherever the mission demands — from airbases to shipyards and, eventually, orbit.' CEO Oluseun Taiwo The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. About Additive Space Technologies Inc., d.b.a. Solideon Solideon is revolutionizing manufacturing by transforming readily available robotic arms into multi-robotic-enabled factories. This innovative approach empowers end-users with the capability to robotically weld, fabricate, and assemble entire structures on-site. By doing so, Solideon is fundamentally reshaping how the industrial base approaches the manufacturing of critical assets, such as ships, submarines, and other large vehicles. About AFRL The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space, and cyberspace forces. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit About AFWERX As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at four hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has awarded over 10,400 contracts worth more than $7.24 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit:
Yahoo
02-06-2025
- Business
- Yahoo
Berkshire Biomedical Awarded NIH Research Grant to Support Clinical Study Program to Evaluate Patient Retention and Other Benefits of the COPA™ System for Take-Home Methadone Medication Management
Funds from the Two-Phase Fast-Track SBIR Grant, Combined, Would Total Approximately $2.9 Million DALLAS, June 2, 2025 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, today announced that it has been awarded the first phase of a two-phase Fast-Track Small Business Innovation Research (SBIR) grant (1 R44DA061908-01A1) from the National Institutes of Health's (NIH) National Institute of Drug Abuse (NIDA). Valued at approximately $2.9 million over 30 months, the two-phase grant will support execution of a clinical study to evaluate patient retention and other benefits of the Company's COPA™ System for Take-Home Methadone Medication Management as part of Medication for Opioid User Disorder (MOUD) treatment. Phase I funds of approximately $326,400 will support the execution of a single-site study. Receipt of the approximate $2.55 million Phase II award will support the execution of an open-label, randomized, parallel multi-site study, which will be contingent on an assessment of the Phase I report, as well as the review and approval of any other documentation necessary for continuation and availability of NIH funds. COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only an Authenticated Intended User (AIU™), upon confirmation of dual biometric identifications (fingerprint and dentition) prior to each dose, with the goal of enhancing patient wellness and providing remote monitoring. "The Fast-Track SBIR grant process is highly competitive, with only 18% of applicants having been chosen under this program in 2023, alone," stated John Timberlake, Chief Executive Officer of Berkshire. This is Berkshire's second Fast-Track SBIR Grant from NIH. The Company received an initial two-phased award totaling $2.2 million (1R44DA057185) in 2022 which extended through 2024, to complete the development of the COPA system. Berkshire's receipt of this newest award reflects the NIH's continued belief in the strength of the technology behind COPA and its potential to significantly increase access to Opioid Treatment Programs for persons suffering from Opioid Use Disorder (OUD) by dramatically increasing the number of persons being allowed to utilize take home therapy." Mr. Timberlake continued, "The requirement to travel to an Opioid Treatment Program (OTP) clinic, daily, has been shown to reduce treatment retention and deter some patients from even starting treatment. A mixed methods study found that take-home dose flexibility among stable patients was associated with receiving more take homes, higher rates of treatment retention, and lower rates of opioid-positive drug tests. Higher retention rates in opioid use disorder medication among patients with OUD were, therefore, associated with better outcomes. There have been a considerable number of retrospective studies evaluating opioid use disorder treatment retention; however, there are very few prospective comparison studies." About the National Institute on Drug Abuse (NIDA)NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit About the National Institutes of Health (NIH)NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit About Berkshire Biomedical Corporation Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with encrypted HIPAA compliant cloud-based and healthcare provider-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU). The Company's lead product under development, the Computerized Oral Prescription Administration System (COPA), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the AIU upon confirmation of dual biometric identification (fingerprint and dentition). Upon receiving regulatory authorization, the Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of oral liquid medication methadone, for Medication Use for Opioid Use Disorder treatment and subsequently for the delivery of controlled medications for the treatment of pain, as those patients have the greatest need for the benefits of COPA's features. In addition, the Company will look to expand COPA use in broader drug therapeutic categories, clinical applications, and businesses that manage the commercialization and data analytics provided by electronic devices to improve outcomes and reduce risk. Additional information about Berkshire Biomedical and the COPA System can be found at The COPA™ System is currently under development, has NOT been reviewed by the U.S. Food and Drug Administration and is not available for commercial sale. Disclaimer: Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Numbers R44DA057185 and R44DA061908-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CONTACT: Berkshire Biomedical Corporationinfo@ Melody CareyFounder, President, and CEORx Communications Group, LLCmcarey@ View original content: SOURCE Berkshire Biomedical Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
Base Operations selected by the US Air Force to provide AI-driven security intelligence for mission resilience and force protection
The Direct-to-Phase II contract was awarded to identify, assess, predict and counter emerging threats, including Small Unarmed Aerial Systems incursions, when operating in dynamic environments with limited intelligence and evolving adversary tactics. WASHINGTON, May 27, 2025 /PRNewswire/ -- Base Operations has been selected by AFWERX for a Direct-to-Phase II contract focused on decoding local threats and providing actionable insights to safeguard the global operations of the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on May 27th 2025, Base Operations will take the next step in its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. "In an era of evolving threats and rapid transformation in federal procurement, sourcing cutting-edge solutions from U.S. startups is essential to maintaining operational readiness and protecting the warfighter. Base Operations is proud to be selected by the Air Mobility Command of the Department of Air Force to deliver advanced, AI-powered threat intelligence. Our platform enhances force protection by anticipating and mitigating risks around critical installations, safeguarding personnel, and effectively countering adversarial foreign espionage. By equipping decision-makers with AI-driven insights, we help strengthen operational resilience and ensure mission success in complex and dynamic environments." Cory Siskind, Founder & CEO at Base Operations The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. About Base OperationsBase Operations decodes the world's threat landscape into actionable security insights that enable organizations to protect their people, assets, and operations. Identify and assess threats, manage risk across your footprint, and make data-driven decisions using granular, street-level intelligence at global scale. Learn more at About AFRLThe Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit About AFWERXAs the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 370 military, civilian and contractor personnel at four hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has awarded over 10,400 contracts worth more than $7.24 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: For press enquiries contact ben@ View original content to download multimedia: SOURCE Base Operations Sign in to access your portfolio
